Ontology highlight
ABSTRACT: Background
Risk-reducing salpingo-oophorectomy (RRSO) around the age of 40 is currently recommended to BRCA1/2 mutation carriers. This procedure decreases the elevated ovarian cancer risk by 80-96% but it initiates premature menopause as well. The latter is associated with short-term and long-term morbidity, potentially affecting quality of life (QoL). Based on recent insights into the Fallopian tube as possible site of origin of serous ovarian carcinomas, an alternative preventive strategy has been put forward: early risk-reducing salpingectomy (RRS) and delayed oophorectomy (RRO). However, efficacy and safety of this alternative strategy have to be investigated.Methods
A multicentre non-randomised trial in 11 Dutch centres for hereditary cancer will be conducted. Eligible
SUBMITTER: Harmsen MG
PROVIDER: S-EPMC4541725 | biostudies-literature | 2015 Aug
REPOSITORIES: biostudies-literature